drugset / Trial / NCT06467513

To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

NCT06467513

Phase 4 Unknown 102 enrolled Zhang XIao Mei
RandomizedSequentialTriple-blindOther

Summary

The objective of this study was to evaluate the effect of esketamine on intraoperative hemodynamics in patients with heart valve replacement and to mitigate postoperative pulmonary complications

Timeline

Start
2024-01-01
Primary completion
2025-05
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.2 mg/kg
Subject Esketamine Other / unclassified 0.4 mg/kg

Indications